Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related OVAS
Mid-Afternoon Market Update: Bed Bath & Beyond Drops After Weak Q3 Results; Tokai Pharmaceuticals Shares Surge
12 Biggest Mid-Day Losers For Thursday

Analysts at Oppenheimer upgraded OvaScience, Inc. (NASDAQ: OVAS) from Market Perform to Outperform, according to Bloomberg. The price target for OvaScience is set to $55. OvaScience's shares closed at $40.51 yesterday.

Latest Ratings for OVAS

Aug 2016JP MorganMaintainsNeutral
Jan 2016OppenheimerDowngradesOutperformPerform
Jan 2016Credit SuisseInitiates Coverage onUnderperform

View More Analyst Ratings for OVAS
View the Latest Analyst Ratings

Posted-In: Top UpgradeUpgrades Analyst Ratings


Related Articles (OVAS)

View Comments and Join the Discussion!